SCHEMBL13312400

SCHEMBL13312400

O=c1[nH]c(=O)c2cccc(-c3ccccc3)c2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FEN1 P39748 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.49
▸ LIMK1 P53667 2/20 0.49
▸ CLK4 Q9HAZ1 2/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ CSF1R P07333 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ PDGFRA P16234 1/20 0.49
▸ LTK P29376 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ MAPK8 P45983 1/20 0.49
▸ CSNK1A1 P48729 1/20 0.49
▸ CDK5 Q00535 1/20 0.49
▸ ACVR1 Q04771 1/20 0.49
▸ TNK2 Q07912 1/20 0.49
▸ AURKB Q96GD4 1/20 0.49
▸ DYRK1B Q9Y463 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.48
▸ PARP1 P09874 2/20 0.48
▸ CA12 O43570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29539083 0.78 FEN1 (0.56) FEN1ALDH1A1LIMK1CLK4MAP4K4
SCHEMBL19893738 0.78 FEN1 (0.56) FEN1ALDH1A1LIMK1CLK4MAP4K4
SCHEMBL15133547 0.78 FEN1 (0.57) FEN1ALDH1A1LIMK1CLK4MAP4K4
SCHEMBL6394871 0.74 ALDH1A1 (0.41) FEN1ALDH1A1KDM4EPARP1CA12
SCHEMBL7028410 0.73 PBRM1 (0.58) ALDH1A1FGFR1KDRKDM4EPARP1
SCHEMBL13312404 0.72 F2 (0.51) FEN1LIMK1CLK4MAP4K4CSF1R
SCHEMBL21023575 0.72 FEN1 (0.51) FEN1ALDH1A1LIMK1CLK4MAP4K4
SCHEMBL6389271 0.72 ADORA3 (0.43) FEN1ALDH1A1KDM4EPARP1CA12
SCHEMBL2922284 0.72 DAO (0.60) CLK4MAP4K4CSF1RFGFR1PDGFRA
SCHEMBL21230721 0.72 PARP1 (0.48) ALDH1A1KDM4EPARP1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 LIPFORD GRAYSON B 2010-06-24 — — US disclosed
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 LIPFORD GRAYSON B 2010-06-24 — — US disclosed
WO-2008030455-A2 SMALL MOLECULE INHIBITORS OF TOLL-LIKE RECEPTOR 9 COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-03-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 TLR9, TLR3, TLR1 FEN1 812/4885ALDH1A1 4793/4885LIMK1 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback